News
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.
Federal documents show he disagreed with conclusions the benefits outweighed the risk of side effects, which are rare.
The leader of the U.S. FDA's division that oversees vaccines, Vinay Prasad, overruled the recommendations of his agency's ...
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
The US Food and Drug Administration (FDA) has provided an update on the risk of myocarditis after receiving an mRNA COVID-19 ...
While both the Novavax vaccine and the newest generation of the mRNA Moderna vaccines had been signed off on by about 30 FDA vaccine officials, Prasad ended up writing overrides for each, restricting ...
Vinay Prasad—the controversial head of vaccine regulation at the US Food and Drug Administration (FDA)—has been named FDA chief medical and scientific officer.1 Traditionally separate roles, his new ...
The FDA’s clunky launch of Elsa, an AI tool to increase efficiency, has sparked concern from agency employees and outside ...
Restricted availability under an FDA-mandated drug safety program has limited the reach of CAR-T cell therapies for certain ...
Cell and gene therapy leaders say the agency’s decision to remove the Risk Evaluation and Mitigation Strategies that had been ...
13d
Investor's Business Daily on MSNThe FDA Shake-Up Continues, And Could Impact Genetic MedicinesThe latest shake-up at the FDA forced out the top two officials in charge of reviewing cell and gene therapies, analysts said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results